The new site, which is ten minutes up the road from Southfield's current location in Basildon, Essex, is due to be ready in time for them to move in at the start of 2022.
When it opens, the centre will continue to offer 15 specialist-led services, but the team is projected to double in size as more specialists, clinicians and staff are recruited over the course of this year
The new premises has been made possible thanks to a big investment by parent company Linnaeus, backed by Mars Veterinary Health.
Southfields managing director Tim Richardson said: "The new hospital is a real statement of intent, a clear signal we are committed to delivering a level of excellence in treatment and care second to none.
"It will provide the region with one of the largest and best-equipped veterinary centres in, not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
"The fabulous facilities include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team, which has already seen its status as one of the most experienced in the industry enhanced by the arrival of James Elliott, a renowned specialist in oncology.
"There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
Southfields says it also aims to lead the industry in terms of staff wellbeing, with yoga and boxercise classes among the activities available to the Southfields team.
Daniel Hogan, Southfields’ hospital director, said: “This is a huge move for us in every way. The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and to offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes, we will have an education centre which will offer some really exciting qualifications and courses for the wider profession.”
Bart Johnson, chief executive of Linnaeus, said: "This move is a reflection of the ambition of Southfields, Linnaeus and Mars to continue providing the best veterinary care in the UK."
For more information about Southfields’ new site, visit https://southfields.co.uk/veterinary-professionals/new-hospital/.
Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on demand later, for those who miss it.
Sam is an Internal Medicine and Feline Specialist and current ISFM Academy lead.
She recently chaired and co-authored the ISFM guidelines on the management of the inappetent hospitalised cat.
The webinar, which counts for one hour’s CPD, will cover:
Sarah Musgrave, Brand Manager at Dechra, said: “Inappetence is a common reason cats present to veterinary practices and it can be caused by multiple conditions.
"Management needs to look beyond just treating the underlying disease as factors such as stress, nausea and pain can play a significant role.
"Untreated inappetence has a substantial negative effect on recovery from illness and surgery, makes medicating cats difficult and may even hasten euthanasia decisions.
"The ‘Feline pawsative about feline inappetence?’ webinar will help educate on feline weight loss, why intervention to improve nutrition is important and the practical steps to treating inappetence.”
https://thewebinarvet.com/webinars/feline-pawsative-about-feline-inappetence.
Norbrook Laboratories Ltd has launched Mycinor tablets (clindamycin), an antibiotic for treating soft tissue infections in dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Clindamycin is one of the leading prescription medicines used to treat soft tissue infections and offers very effective treatment particularly for dental and oral infections.
"Mycinor can be used to treat infected mouth cavities and oral infections and to provide antimicrobial cover prior to dental procedures such as tooth removal, scale & polish etc. Beyond dental expertise, Mycinor can also be used to treat soft tissue infections, skin infections in the form of superficial pyoderma and osteomyelitis bone infections. Mycinor is a fast acting antibiotic, rapidly absorbed into the body with effective levels within 30 minutes of administration."
Mycinor is available as 25mg, 75mg and 150mg in packs of 100tablets, and as a 300mg tablet in a pack of 150 tablets. Rebekah added: "Mycinor is a very effective and safe antibiotic and is ideal for long and short term treatments. It can be dosed once daily or at twice daily intervals if preferred."
For more information, visit www.norbrook.com
Elanco Animal Health has announced the launch of Osurnia, a new treatment which it says will drive compliance when treating canine otitis externa infections.
According to the company, compliance with daily ear drops has been shown to be poor, with up to 80% of owners administering the incorrect dose to their pet. The most common reason for a lack of compliance is the difficultly in applying the drops1.
Elanco says that Osurnia has the potential to improve compliance in treating otitis externa significantly, because unlike other medications which require 5-28 doses during the course of treatment2, Osurnia only needs two-doses given a week apart.
Osurnia contains a gel formulation of three active ingredients including the antibiotic florfenicol, which is new to companion animal treatment in the UK, terbinafine, which inhibits the growth of yeast as demonstrated for Malassezia spp., and the glucocorticosteroid, betamethasone acetate, to help relieve discomfort.
Osurnia is administered in a pre-measured, single-dose tube designed to ensure the right dose every time. It has a flexible, soft tip designed to make treatment with Osurnia a comfortable experience for the dog. The gel formulation squeezes out of the tube and spreads through the ear, adhering inside the ear canal for long-lasting action. The dose is the same for any dog, regardless of size and weight.
Alice Laurens, DVM MRCVS, dermatology marketing manager at Elanco Animal Health said: “Otitis externa is a common challenge for both vets and clients, with ear infections among the ten most frequent reasons for dogs to be presented with vets, affecting up to 20% of dogs3.
“Osurnia is an innovative, effective treatment that is administered in just two doses ensuring it is much more convenient for pet owners thereby increasing the likelihood that they will complete the entire treatment schedule leading to more comfortable dogs and peace of mind for owners.”
Elanco has produced a client leaflet on treating otitis externa with Osurnia. For further information, or to order client leaflets, please contact your local Elanco Animal Health Territory Manager or email elancoCAH.uk@elanco.com.
References
The book is described as giving comprehensive information to support the diagnosis and treatment of commonly seen pathologies of dogs and cats, such as haematology, immunology, diagnostic imaging, respiratory diseases, cardiovascular medicine, reproductive system disorders, gastrointestinal disorders, as well as hepatobiliary and exocrine pancreas disorders.
Each chapter has been authored by an internationally recognised expert in their field.
Improve says its books support delegates studying for its Postgraduate Certificate, but are also a useful reference source for other veterinary surgeons.
John Douglass, General Manager of Improve International, said: "Following the positive response to our first textbook, the Improve International Manual of Small Animal Surgery, we felt it was important to follow up with a small animal medicine equivalent. We’re therefore very happy to unveil volume one of the Improve International Manual of Clinical Small Animal Internal Medicine and look forward to the launch of the second volume later this year."
He added: "Our textbooks focus on the practical application of current veterinary knowledge, offering top tips and key advice throughout expressed in an engaging and highly visual format to ensure that they are perfect for those in need of a quick ‘look up’ in practice.”
The new books can be bought from www.improveinternational.com/uk/books, www.5mbooks.com or from booksellers worldwide. They are also available in Spanish with translations into additional languages planned.
The service is being led by Isuru Gajanayake, a board-certified specialist in veterinary nutrition. He said: “Since launching our clinical nutrition service last year, we have seen a number of cases in which patients have been either dehydrated or malnourished, sometimes both.
“Working alongside our other services in a truly multidisciplinary approach, we have been able to offer suitable treatment to support a significant number of dogs and cats.
“With the launch of the parenteral nutrition service, we can now expand this offering and, in doing so, become one of only a very few referral centres across the UK to provide this as a specialist service.
“Patients who are given parenteral nutrition will be hospitalised in our advanced intensive care unit to ensure they can be monitored closely by our specialist emergency and critical care (ECC) team, who provide exceptional expertise in critical care and treatment for every patient when they need it most.
Isuru added that the addition of the clinical nutrition and parenteral nutrition services at Willows ensures that there is a much greater emphasis on nutrition and hydration for all patients at the centre, whatever their underlying illness.
For more information, visit www.willows.uk.net or search for Willows Veterinary Centre and Referral Service on Facebook.
The Boehringer Academy (www.boehringer-academy.co.uk) contains hundreds of hours of CPD material on equine, companion and production animals. It comprises a mixture of webinars, podcasts, short videos and downloadable documents, which can be viewed at any time. The site keeps a CPD log for each user and provides downloadable certificates.
Boehringer’s Small Animal Marketing Team Leader, Jemima Mead said: "We already have just over 15,000 vets and nurses in the UK and Ireland currently registered with the Academy.
"New and existing members are eligible to receive the Boehringer Academy colouring book. They simply have to visit www.boehringer-academy.co.uk and complete their profile. In addition, everyone completing their profile will be entered into a draw to win an iPad Pro and Apple Pencil."
The module, which was produced with Ian Wright, head of the specialist parasitology organisation, ESCCAP, aims to help veterinary professionals with their discussions with pet owners about parasite management.
Andrea Tarr, Veterinary Prescriber’s founder and director said: "Surveys across Europe have shown that the public have poor understanding about the need for endoparasite control in their pets, including the risks endoparasites pose, such as zoonosis, and about routine preventative treatment."
Consultations are delivered online using video conferencing software, with the aim being to provide an immediate diagnosis and treatment plan. However, if a diagnosis cannot be made remotely, or the situation requires intensive medical or surgical intervention, Optivet offers non-contact clinical facilities in Hampshire, London and the Isle of Wight, or will recommend other, closer ophthalmology facilities if necessary.
Optivet says it has the medical and surgical expertise to deal with any ongoing issues and follow-up is provided remotely wherever possible.
Rob Lowe, RCVS Specialist in Veterinary Ophthalmology and founder of Optivet, said: “We have come up with an innovative, non-contact ophthalmology solution for both the present and the future. Optivet’s response time and immediate availability of an ophthalmology specialist is unmatched in the UK.
"Once you become a client, you become part of the Optivet family. Our amazing team will work with you throughout the patient journey to provide the highest level of care.”
For more information, visit: remote.optivet.com
The company has published data from its 2021 Assure Ewe subsidised testing scheme, which found that 48% of farms that submitted samples after last year’s lambing season tested positive for EAE1 caused by Chlamydia abortus.
This, Ceva says, mirrors the results from the 2020 testing initiative, demonstrating that EAE remains a significant issue on UK farms.
Katherine Timms BVetMed (Hons) MRCVS, ruminant veterinary advisor at Ceva Animal Health said: “EAE is a significant problem on UK farms, and it can be exceptionally expensive and frustrating to deal with, as infected sheep aborting and shedding have the potential to cause an abortion storm the following year.
“Any abortion outbreak should therefore be identified and managed as quickly and effectively as possible to help prevent the rest of the ewes in the flock from becoming infected.
"Vaccination and strict biosecurity provide the best protection against EAE and farmers can vaccinate their ewes from five months of age until four weeks prior to tupping, as long as the ewe is not in lamb.”
For further information, contact your local Ceva Animal Health account manager or visit www.enzooticabortion.co.uk.
Reference
The coils need to be cooled to -460 °F in order to get good quality images.
To achieve the same result without helium, Hallmarq’s new MRI uses a conduction-based cooling system in a strong vacuum, which eliminates the need for helium, a quench pipe, oxygen monitor, or any additional power.
This, Hallmarq says, makes the new system more environmentally friendly than its helium-based counterparts and reduces the upfront and ongoing costs of offering a veterinary MRI service to patients.
The new technology comes in response to growing concerns over helium supply.
Extraction and usage of helium is quickly outpacing its natural synthesis, as a result of which, Hallmarq says helium prices have soared from £12.75 per litre in December of 2017 to between £50 and £55 per litre in June 2022.
For veterinary hospitals already using high-field MRI machines, or for those considering them in the future, reliance on the 1,500-2,200 litres of helium required to keep a standard MRI functioning may not be sustainable.
Hallmarq’s Chief Technology Officer Dr. Steve Roberts said: “Hallmarq’s Zero-Helium Small Animal 1.5T MRI system increases access to diagnostic care for small animal patients, while lessening the financial, environmental and supply chain risks associated with traditional helium-based MRI systems."
www.hallmarq.net.
Virbac Animal Health has announced that registrations on BackHome BioTec, the company's microchip identification service, were moved to the Petlog Database with effect from Monday 12 September 2011.
Virbac says it moved to the UK's largest independent microchip registration database in order to offer an enhanced level of service and support, both to veterinary staff and pet owners.
Practices using the BackHome BioTec system are being asked to log onto www.virbacbackhome.co.uk to create a new account.
Gillian Brown, Product Manager for BackHome at Virbac, said: "BackHome has established itself as a popular, cost-effective and easy to use microchipping system. We believe that in appointing Petlog to manage our registrations we will now be offering a 'best of breed' service for veterinary staff and pet owners.
"We're extremely grateful to Celia Walsom, Petlog Executive, and her team. They have demonstrated unfailing energy, expertise and total dedication to ensuring this move has run smoothly and effectively for all our customers. I am confident that they will benefit from Petlog's commitment to provide a comprehensive identification service which is easy, convenient and secure to use.
"All our existing customers need to do is go to the new website (www.virbacbackhome.co.uk/) and set up an account - it's a simple and quick process. We'll also be providing a range of promotional materials to help them communicate the change to their own clients."
Petlog is owned and managed by the Kennel Club. Virbac says it is fully data compliant and defers income to ensure it can honour its lifetime promise to pet owners. Its Lost and Found helpline is available 24/7, 365 days a year and it is also a founder member of the European Pet Network.
Further information on BackHome BioTec is available on the new website, which also contains a direct link to Petlog.
For further information about BackHome BioTec, please contact your Virbac Territory Manager or call the company on 01359 243243.
Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate.
The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing treatment of Angiostrongylus vasorum claim, Advocate is now indicated for its prevention, using monthly spot-on applications.
This comes at a time when, according to Bayer, independent market research shows that vets are diagnosing Angiostrongylus vasorum at an increasing rate. Figures for 2010 place the incidence of vets who have confirmed cases at 37%, more than double the 16% confirmed in 2008, with a further 19% of vets reporting suspected cases.
Bayer is also stepping up its 'Be Lungworm Aware' consumer campaign, with the addition of a local and national radio campaign throughout October. The public information style advert will warn owners of the dangers associated with the parasite A.vasorum, and urging them to stay vigilant for signs their dog may be infected.
Veterinary staff can also direct clients who wish to learn more about lungworm to http://www.lungworm.co.uk/.
For more information on Advocate, please contact your sales representative or telephone Bayer on 01635 563000.
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and ProteqFlu Te.
In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.
The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted2.
Elanco also highlights a recent study3 which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination. This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.
References:
The webinar, titled: ‘When the coughing won’t stop…. what to do when standard BRD treatment protocols aren’t getting to the bottom of it’, aims help vets manage complex outbreaks that happen despite best practice management and treatment protocols.
The full programme includes:
The event is being held live so you can submit questions to the speakers, but the session will be recorded, so it can be watched again later.
Attendees will receive a certificate for one hour of CPD and the link to the recorded webinar.
To register, email the event team by 27 November 2020 at brdwebinar-group@ceva.com. In the email, please give your name and the email address to which you would like the registration link sent.
As part of the scheme, Linnaeus offers one-to-one mentoring, professional and clinical skills development in primary care practices across the UK as part of the scheme.
The group, which now has more than 3,000 employees, delivers all clinical training in-house through its network of specialists, referral clinicians, certificate holders and primary care clinicians.
The 2021 programme applications will remain open until the end of May, unless all positions are filled sooner.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This will be the fourth cohort to join our GDP and we’re looking forward to building on the successes we have enjoyed over the last three years.
“This has been a challenging year for obvious reasons, so it has been extremely heartening to see our new vets rise to that challenge and continue their professional journeys with our support.
“We’re excited to hear from the next intake of new vets and look forward to supporting them in their transition to clinical practice and recognise the additional challenges they faced joining the profession in the midst of a global pandemic.”
For more information, visit graduates.linnaeusgroup.co.uk or www.instagram.com/linnaeusgdp.
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
The Royal College of Veterinary Surgeons is seeking feedback on a new draft Code of Professional Conduct for Veterinary Nurses.
The new draft Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Nurses, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
It is the benchmark for professional conduct against which registered veterinary nurses will be measured in any hearings on serious professional misconduct held by the recently-introduced VN Disciplinary Committee.
The purpose of the review is to ensure that guidance to the profession, and the public, is clear, for example, using consistent language to distinguish between what must be done and what is advised.
The new Code is a short, principles-based document, using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance.
The consultation follows an earlier one for a new draft Code for veterinary surgeons that closed at the end of June: the new Code for veterinary nurses follows the format and style of that for veterinary surgeons. Comments made during the veterinary surgeon consultation will be taken account of alongside comments made during this new consultation.
For the first time, the draft proposes that veterinary nurses make a declaration on joining the VN Register, which underlines the primary importance of animal health and welfare: "I PROMISE AND SOLEMNLY DECLARE that my constant endeavour will be to ensure the welfare of animals committed to my care and that I will pursue the work of my profession with integrity and accept my responsibilities to my clients, the public, the profession and the Royal College of Veterinary Surgeons."
Comments on the proposed draft are invited from the veterinary nursing profession, the veterinary profession and the public, particularly on the issue of whether the Codes for veterinary nurses and veterinary surgeons ought to be combined.
Andrea Jeffery, the RCVS Veterinary Nurses Council member who led the group tasked with developing the new Code, said: "It is 50 years since the start of the veterinary nursing profession and the changes proposed in the Code reflect the development of our professional role over this time.
"This new Code is a simplified document that focuses on key principles and which will be supported by more detailed guidance. Although it follows the format of the draft Code for veterinary surgeons, it is important that we recognise our unique position as veterinary nurses."
The new Code, together with the consultation paper, can be downloaded at www.rcvs.org.uk/VNcodeconsultation.
Comments should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 21 October 2011.
The first is Design Hub, a self-service marketing portal which allows practices to choose from a variety of designs for posters, social media posts and other collateral and brand them with the practice logo. The portal includes a planner which details noteworthy dates, veterinary campaigns and events that practices might want to include in their marketing plans.
Member practices using the new portal during February also have the chance to enter a competition to win £500 Love2shop vouchers.
The second resource is a pets portal which the company says will make it easier to access live information about pets enrolled on its health plans, make administrative changes, process refunds or cancellations and soon, add new pets.
From July the pets portal will compatible with tablets and other mobile devices, so practice staff can move out from behind the desk and have conversations with pet owners in the waiting or consulting rooms.
Paul Bates, Practice Development Specialist, said: "We had already identified that practices wanted to be able to register plans and change details online. It was important for us to also ensure that the tool we developed had the desired functionality and was robust enough to handle large volumes of data being entered simultaneously across the country.
"We also wanted it to be fit for purpose so that if we want to develop more advanced features going forwards, we don’t have to recreate the wheel and can build on what we have already. The portal will be really useful in its own right and gives us a great launching pad for future development."
To access the new portals, email: pethealthplanscomms@denplan.co.uk, or contact your Simplyhealth Professionals Practice Support Advisor or Business Development Consultant.
For more information about Simplyhealth Professionals visit http://www.pethealthplans.co.uk/vets.
Two hundred members of the profession took part. The main results were:
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
The series looks in detail at some of the most important issues dental specialists are seeing in pets.
The first webinar in the series, which is going live on Tuesday 3rd November at 8:00pm, looks at the impact periodontal disease has on both cats and dogs.
Co-speaker and veterinary dental specialist, Jens Ruhnau DVM, DEVDC (above, left) discusses the importance of understanding and treating the condition: "Research has shown that over 80% of dogs over the age of three, and the majority of cats, are impacted by periodontal disease. Treating the disease early and correctly is key to reducing further spread, secondary infection, and ultimately improving the quality of life of the animal".
The second webinar in the series, which will be live on Tuesday 10th November at 8:00pm, shares advice on treating tooth fractures in pets. Looking at tips on how to perform an effective oral examination, along with reviewing recent studies on the fracture limits of teeth in pet dogs.
Co-speaker and founder of DentalVets, Norman Johnston (above, right) said: "Tooth fractures are very common in both cats and dogs, and can be caused by a variety of reasons. Looking in more detail at the diagnostic process, treatments options and being aware of what objects can cause damage will help veterinary professionals, and in-turn owners, understand more about the risk of fractures."
Both webinars are free to attend, to find out more information and to register click here. https://www.thewebinarvet.com/pages/mars-petcare-free-webinars-tooth-fractures-periodontal-disease
Prior to becoming COO, Tim was Managing Director of three referral hospitals owned by Linnaeus – Davies Veterinary Specialists, London Veterinary Specialists and Southfields Veterinary Specialists – and a number of its primary care sites.
Prior to joining Linnaeus, Tim worked in Iceland, where he was a vet for the Icelandic Government.
On his return from Iceland in 2016, he joined Village Vet and then progressed into a range of regional management and practice leadership positions across the industry.
Tim said: "I am proud to be part of our wonderful, unique industry that, although currently facing a number of challenges, continues to make such a difference to the lives of our patients and their owners every day.
“In my first vet role in mixed practice, I was fortunate to receive brilliant support, guidance and encouragement from my team.
"Since then, I have always wanted to do the same for my colleagues, particularly those who are just starting their careers.
“I have used my experience within the veterinary profession to support some fantastic teams at Linnaeus.
"Becoming COO is an honour and opportunity that will enable me to help even more people across the business.”
The first is a new formulation of Sustain, which the company says will be the first UK veterinary product for cats to contain a prebiotic, probiotic and postbiotic.
The company has also launched Gomega for Cats, which contains a purified fish oil source of Omega 3 essential fatty acids which VetPlus says supports cardiovascular health and kidney function.
Jackie Marshall, Technical Advisor at VetPlus, said: “The launch of these two products will help our veterinary partners provide the best care for felines from gastrointestinal support through to aiding with renal and cardiac health.
Sustain for Cats and Gomega for Cats are now in stock and available from veterinary wholesalers.
www.vetplus.co.uk
Defra has confirmed that equine infectious anaemia (EIA) has been detected in two horses in Wiltshire following importation from Romania via Belgium.
The premises is currently under restriction and the two infected horses will be humanely destroyed in line with existing regulations. The other horses on the premises will be subject to epidemiological investigation in the coming weeks. A further two horses have also been under investigation and test results have proved negative.
The animals arrived in a group of 10 horses, nine of which originated from Romania and one from Belgium. The nine Romanian horses were tested for EIA as part of routine post-import testing. Seven horses all tested negative. The horse that originated in Belgium is due to be tested shortly.
Chief Veterinary Officer, Nigel Gibbens said: "This is the first case of equine infectious anaemia infected animals being imported into Great Britain since 1976 and shows the success of our post import testing regime. These were apparently healthy horses carrying a notifiable disease that we are keen to keep out of Great Britain. After considering the risk I have decided to take appropriate action and humanely destroy these two horses that tested positive."